Research scientist,
permanent position in the “Centre National de Recherche Scientifique” (CNRS)
Laboratoire "Maladies Infectieuses & Vecteurs : Ecologie, Génétique, Evolution & Contrôle" (MIVEGEC)
Département "Perturbation, Évolution, Virulence" – Équipe "Virostyle"
Membre du Centre de Recherche sur l'écologie & l'évolution de la Santé (CREES)
Membre du bureau d'administration du réseau Phages.fr et page perso
UMR 5290 UM-CNRS-IRD
911 Avenue Agropolis, B.P. 64501 – Bureau 316 – 34394 Montpellier Cedex 5, France
Téléphone : [00 33] (0)4 67 41 63 72
ORCID (0000-0001-8234-1308)
HAL
My career has been devoted to study the evolution of viruses (especially in temporaly and/or spatialy variable environments), both infecting plants, insects and bacteria. After a PhD (Université de Paris 6, UPMC) dedicated at the understanding of the key parameters of the intra-host evolution of the Cauliflower mosaic virus (CaMV), I carried out 3 years post-doctoral research with Paul Turner at the University of Yale (USA) and Olivier Tenaillon at Hopital Bichat (France) in which I investigated the effect of co-infection on genomic and phenotypic evolution of bacteriophage populations. In 2005, I initiated my current position at the CNRS where I established experimental evolution of different viruses (plant caulimovirus CaMV but also insect densovirus JcDNV and bacteriophages Lambda and PhiX174) and also tested experimentally the trade-off between virulence and transmission of some of these viruses (CaMV and JcDNV).
In 2014, I decided to come back on phage'evolution through a collaboration with Jo-Ann Passmore (University of Cape-Town, South-Africa), Ignacio Bravo (MIVEGEC, Montpellier, France) and Marie Vasse (post-doc, MIVEGEC, Marie-Curie grant) with whom we are working on disturbance of microbial vaginal ecosystem that may results on dysbiosis (in particular, bacterial vaginosis).
I also work with Guillaume Martin (CNRS, ISEM, Montpellier, France) and Yoann Anciaux (post-doc ISEM-MIVEGEC, Montpellier, France) on in vitro evolutionary rescue of bacteria stressed by antibiotics and/or bacteriophages targetting E.coli. I also participate to the project Phag-One leaded by Frederic Laurent and Tristan Ferry (Hospice Civile de Lyon) on the bacteriophage' host-range targetting Staphylococcus epidermidis and E.coli. Finally, I'm currently also working on Salmonella 'bacteriophages in order to perform long-term efficiency of bacteriophage biocontrol.
Main subject of research : “evolution proof” bacteriophage therapy / phage adaptation (host-range and virulence)
Past training
° Authors contributed equally to the work # corresponding author(s)
2022-2025 : “Salmonella biocontrol” – in charge : Amandine Maurin
2022-2025 : “Study of the antagonistic co-evolution between therapeutic bacteriophages and carbapenem-resistant E. coli” - in charge Elsa Beurrier
2024-2024 : “étude des savoirs, savoir-faire et enjeux de la domestication de bactériophages à usages thérapeutiques” - in charge Charlotte Whittington (co-direction avec Charlotte Brives (CNRS, Bordeaux)